Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT GolfBT MindrushBT Best Banks
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Gland Pharma Ltd
Gland Pharma Ltd

Gland Pharma Ltd (GLAND) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 67,467
Apr 25, 2025
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹1,443.80
₹-21.70 (-1.76%)
1,430.70Low
Today’s Performance
1,476.00High
1,277.80Low
52 Week’s Performance
2,220.95High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day-1.76%
  • 1 Week1.11%
  • 1 Month-8.99%
  • 3 Months-5.94%
  • 6 Months-10.75%
  • 1 Year-16.58%
  • 3 Years-23.66%
  • 5 Years-4.24%

bt_logoCompany Stories

Pharma stocks: Sun Pharma, Aurobindo, Gland, DRL in focus after Trump tariff warningAurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far. Glenmark Pharma is down 10 per cent for the week month period and 14.45 per cent year-to-date. Sun Pharma has fallen 2.95 per cent in the past one week; Zydus Lifesciences has declined 1.73 per cent, Dr Reddy's Labs 2.23 per cent and Lupin 4.14 per cent, respectively.
    View more

    bt_logoPeer Comparison

    Price

    bt_logoStock Summary

    • Face Value (₹)1.00
    • Beta0.73
    • 52-Week Low (₹)1,277.80
    • 52-Week High (₹)2,220.95
    • Price-to-Book (X)*2.75
    • Dividend Yield (%)1.36
    • Price-to-Earnings (P/E) (X)*34.28
    • Earnings Per Share (₹)42.75
    • Market Cap (₹ Cr.)*24,145.05
    * Values as of last close price

    bt_logoCOMPETITORS

    BT TV

    The Power Of Presence - An Underrated Leadership Trait1:03The Power Of Presence - An Underrated Leadership Trait
    Gold or Silver?| Jim Rogers: I’ll Buy More Gold If Prices Dip – Here’s Why0:43Gold or Silver? | Jim Rogers: I’ll Buy More Gold If Prices Dip – Here’s Why
    After Pahalgam Bloodshed, India Strikes Back: Indus Treaty Halted, Borders Shut, Justice Promised3:59After Pahalgam Bloodshed, India Strikes Back: Indus Treaty Halted, Borders Shut, Justice Promised
    PM Modi From Bihar Stage: “India Will Punish Pahalgam Attackers Beyond Their Imagination4:32PM Modi From Bihar Stage: “India Will Punish Pahalgam Attackers Beyond Their Imagination"
    Market Masters | Kenneth Andrade On Trump Tariff Impact, Market Outlook, Sectors, Mutual Funds & More24:48Market Masters | Kenneth Andrade On Trump Tariff Impact, Market Outlook, Sectors, Mutual Funds & More
    Gold at Historic Highs: Jim Rogers Explains Why He’s Holding and Still Buying Bullion0:43Gold At Historic Highs: Jim Rogers Explains Why He’s Holding And Still Buying Bullion
    On Ground In Pahalgam: Terror Attack Empties The Valley’s Most Loved Tourist Town In Just Hours2:47On Ground In Pahalgam: Terror Attack Empties The Valley’s Most Loved Tourist Town In Just Hours
    Akshay Bhagwat On Nestle’s Momentum V/S HUL’s Stagnation1:01Akshay Bhagwat On Nestle’s Momentum V/S HUL’s Stagnation
    India Suspends Indus Water Treaty: Dry Days Ahead For Pakistan & Its Economy?4:10India Suspends Indus Water Treaty: Dry Days Ahead For Pakistan & Its Economy?
    Central Banks Trigger Gold Surge – What It Means For You1:02Central Banks Trigger Gold Surge – What It Means For You
    View more

    bt_logoFinancial Analysis

    Income Statement (₹ Cr.)

    No data for consolidated quarterly .

    Balance Sheet (₹ Cr.)

    No data for consolidated quarterly .

    Cash Flow (₹ Cr.)

    No data for consolidated quarterly .

    bt_logoRatio Analysis

    Return on Equity (%)
    No Data For consolidated ROE.
    Return on Assets (%)
    No Data For consolidated ROE.
    Price-to-Earnings (P/E) (X)
    No Data For consolidated ROE.
    Price to Book (x)
    No Data For consolidated ROE.
    Return on Capital Employed (%)
    No Data For consolidated ROE.
    Enterprise Value to EBITDA (X)
    No Data For consolidated ROE.
    Net Profit Margin (%)
    No Data For consolidated ROE.
    Gross Profit Margin (%)
    No Data For consolidated ROE.
    EBITDA Margin (%)
    No Data For consolidated ROE.

    bt_logoShare Holding Pattern

    Summary (As on 31 Mar 2025)

    bt_logoDeals

    25 Jan, 2024BUY
    SOCIETE GENERALE
    Qty257761
    Average Price₹1936.95
    25 Jan, 2024SELL
    BNP PARIBAS ARBITRAGE
    Qty257761
    Average Price₹1936.95
    02 Sep, 2021BUY
    GOLDMAN SACHS FUNDS GOLDMAN SACHS INDIA EQUITY PORTFOLIO
    Qty400293
    Average Price₹3903.05
    02 Sep, 2021SELL
    GOLDMAN SACHS INDIA FUND LIMITED
    Qty400293
    Average Price₹3903.05
    *Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.

    bt_logoFAQ's

    What was Gland Pharma Ltd share price previously?
    Gland Pharma Ltd share price was down by -1.76% from the previous closing price of ₹1,465.50.
    Who are peers of Gland Pharma Ltd?
    The peers of Gland Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd.
    Who is/are the promoter/promoters of Gland Pharma Ltd?
    The promotor/promotors of Gland Pharma Ltd are Yiu Kwan Stanley Lau, SRINIVAS SADU, UDO JAHANNES VETTER, C S N Murthy, ESSAJI GOOLAM VAHANVATI, Naina Lal Kidwai, Jia Ai (Allen) Zhang, Wenjie Zhang, Wei Huang.
    What has been 52-week high of Gland Pharma Ltd stocks?
    The highest price of Gland Pharma Ltd stock is ₹2,220.95 in the last 52-week.
    What is the share price of Gland Pharma Ltd (GLAND) today on NSE?
    As on Apr 25, 2025 Gland Pharma Ltd (GLAND)’s share price on NSE is Rs 1443.8
    What is the market cap of Gland Pharma Ltd (GLAND)?
    The current market capitalisation of Gland Pharma Ltd (GLAND) is 24,145.05 crores
    What is Gland Pharma Ltd Share symbol?
    The symbol of Gland Pharma Ltd is GLAND.
    What is the PE ratio of Gland Pharma Ltd (GLAND)?
    The current PE ratio of Gland Pharma Ltd (GLAND) is 34.28.
    What is the PB ratio of Gland Pharma Ltd (GLAND)?
    The current PB ratio of Gland Pharma Ltd (GLAND) is 2.75.
    Today’s High & Low share prices of Gland Pharma Ltd (GLAND) on NSE?
    Today, the share price of Gland Pharma Ltd (GLAND) on NSE touched a high of Rs 1476 and a low of Rs 1430.7
    What price did Gland Pharma Ltd (GLAND) shares open on the NSE today?
    On NSE, the share price of Gland Pharma Ltd (GLAND) opened at Rs 1470.4
    What is the 52-week high of Gland Pharma Ltd (GLAND)?
    The 52-week high price of Gland Pharma Ltd (GLAND) is Rs 2,220.95
    What is the 52-week low of Gland Pharma Ltd (GLAND)?
    The 52-week low price of Gland Pharma Ltd (GLAND) is Rs 1,277.80

    bt_logoAbout Gland Pharma

    Gland Pharma Ltd, incorporated in the year 1978, has its registered office in Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043, 91-40-30510999, 91-40-30510800. The main industry in which Gland Pharma Ltd operates is Pharmaceuticals - Indian - Formulations.

    Auditor/Auditors for Gland Pharma Ltd is/are Deloitte Haskins & Sells. In the main management, Yiu Kwan Stanley Lau is chairman and is the company secretary for Gland Pharma Ltd.

    • YKSL
      Yiu Kwan Stanley LauChairman & Independent Directo
    • SS
      SRINIVAS SADUManaging Director & CEO
    • UJV
      UDO JAHANNES VETTERNon-Exec & Non-Independent Dir
    • CSNM
      C S N MurthyIndependent Director
    • EGV
      ESSAJI GOOLAM VAHANVATIIndependent Director
    • NLK
      Naina Lal KidwaiIndependent Director
    • JA(Z
      Jia Ai (Allen) ZhangNon-Exec & Non-Independent Dir
    • WZ
      Wenjie ZhangNon Executive Director
    • WH
      Wei HuangAdditional Director

    bt_logoTop Stories

    DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

    DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this website, you agree to the Terms of Service and Privacy Policy.